RNA-binding proteins in tumor progression
H Qin, H Ni, Y Liu, Y Yuan, T Xi, X Li… - Journal of hematology & …, 2020 - Springer
RNA-binding protein (RBP) has a highly dynamic spatiotemporal regulation process and
important biological functions. They are critical to maintain the transcriptome through post …
important biological functions. They are critical to maintain the transcriptome through post …
[HTML][HTML] Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance
PB Gupta, I Pastushenko, A Skibinski, C Blanpain… - Cell stem cell, 2019 - cell.com
Our traditional understanding of phenotypic plasticity in adult somatic cells comprises
dedifferentiation and transdifferentiation in the context of tissue regeneration or wound …
dedifferentiation and transdifferentiation in the context of tissue regeneration or wound …
Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1–CD44 axis
Background & Aims Tumor-microenvironment factors and cancer stem cells (CSCs) play a
critical role in the aggressiveness of pancreatic cancer (PC). However, the degree to which …
critical role in the aggressiveness of pancreatic cancer (PC). However, the degree to which …
RNA-binding proteins in cancer: old players and new actors
RNA-binding proteins (RBPs) are key players in post-transcriptional events. The
combination of versatility of their RNA-binding domains with structural flexibility enables …
combination of versatility of their RNA-binding domains with structural flexibility enables …
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology
D Osuna de la Peña, SMD Trabulo, E Collin… - Nature …, 2021 - nature.com
Patient-derived in vivo models of human cancer have become a reality, yet their turnaround
time is inadequate for clinical applications. Therefore, tailored ex vivo models that faithfully …
time is inadequate for clinical applications. Therefore, tailored ex vivo models that faithfully …
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …
Epithelial mesenchymal transition in embryonic development, tissue repair and cancer: a comprehensive overview
DH Kim, T Xing, Z Yang, R Dudek, Q Lu… - Journal of clinical …, 2017 - mdpi.com
The epithelial mesenchymal transition (EMT) plays a central role in both normal
physiological events (eg, embryonic development) and abnormal pathological events (eg …
physiological events (eg, embryonic development) and abnormal pathological events (eg …
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
P Zhou, B Li, F Liu, M Zhang, Q Wang, Y Liu, Y Yao… - Molecular cancer, 2017 - Springer
The mechanical properties of epithelial to mesenchymal transition (EMT) and a pancreatic
cancer subpopulation with stem cell properties have been increasingly recognized as potent …
cancer subpopulation with stem cell properties have been increasingly recognized as potent …
[HTML][HTML] Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Epithelial-mesenchymal transition (EMT) is a cellular biological process involved in
migration of primary cancer cells to secondary sites facilitating metastasis. Besides, EMT …
migration of primary cancer cells to secondary sites facilitating metastasis. Besides, EMT …
Cancer the 'RBP'eutics–RNA-binding proteins as therapeutic targets for cancer
RNA-binding proteins (RBPs) play a critical role in the regulation of various RNA processes,
including splicing, cleavage and polyadenylation, transport, translation and degradation of …
including splicing, cleavage and polyadenylation, transport, translation and degradation of …